5-MAPB
| Clinical data | |
|---|---|
| Other names | 5-(N-Methyl-2-aminopropyl)benzofuran |
| Routes of administration | Oral, Insufflated, Rectal |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C12H15NO |
| Molar mass | 189.25 g/mol (freebase) 225.7 g/mol (HCl salt) g·mol−1 |
| 3D model (JSmol) | |
| |
| |
5-MAPB, also known as 5-(N-methyl-2-aminopropyl)benzofuran, is an entactogen and designer drug of the amphetamine family that is similar to MDMA in its structure and effects.
It has been patented by Tactogen as an entactogen for potential use as a medicine.